Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society..

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

2.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

3.

Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.

Lu E, Dahlgren L, Sadovnick A, Sayao A, Synnes A, Tremlett H.

Mult Scler. 2012 Apr;18(4):460-7. doi: 10.1177/1352458511422244.

PMID:
21914689
4.

Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.

Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L, Sadovnick AD, Traboulsee A, Tremlett H.

CNS Drugs. 2014 May;28(5):475-82. doi: 10.1007/s40263-014-0154-6.

PMID:
24643915
5.

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.

Lu E, Wang BW, Guimond C, Synnes A, Sadovnick D, Tremlett H.

Neurology. 2012 Sep 11;79(11):1130-5. doi: 10.1212/WNL.0b013e3182698c64. Review.

6.

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C.

Rheumatology (Oxford). 2014 Apr;53(4):757-63. doi: 10.1093/rheumatology/ket390.

7.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Weber-Schoendorfer C, Schaefer C.

Mult Scler. 2009 Sep;15(9):1037-42. doi: 10.1177/1352458509106543.

PMID:
19692433
8.

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS.

Neurology. 2005 Sep 27;65(6):802-6. Review.

PMID:
16093457
9.

Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.

Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.

Am J Gastroenterol. 2010 Sep;105(9):2003-8. doi: 10.1038/ajg.2010.138.

PMID:
20700117
10.

Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population.

De Las Heras V, De Andrés C, Téllez N, Tintoré M; EMPATIE Study Group..

Mult Scler. 2007 Sep;13(8):981-4.

PMID:
17623725
11.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society..

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054.

PMID:
24403285
12.

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society..

Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb.

PMID:
21079181
13.

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

Fernández Liguori N, Klajn D, Acion L, Cáceres F, Calle A, Carrá A, Cristiano E, Deri N, Garcea O, Jaureguiberry A, Onaha P, Patrucco L, Riccio P, Rotta Escalante R, Saladino Ml, Sinay V, Tarulla A, Villa A.

Mult Scler. 2009 May;15(5):555-62. doi: 10.1177/1352458509102366.

PMID:
19299437
14.

Parenthood and immunomodulation in patients with multiple sclerosis.

Hellwig K, Haghikia A, Gold R.

J Neurol. 2010 Apr;257(4):580-3. doi: 10.1007/s00415-009-5376-z.

PMID:
19936821
15.

Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K.

Br J Clin Pharmacol. 2013 Apr;75(4):1134-41. doi: 10.1111/j.1365-2125.2012.04426.x.

16.

Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women.

Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, Liu D, Zeng X, Zhang F.

J Matern Fetal Neonatal Med. 2012 Mar;25(3):261-6. doi: 10.3109/14767058.2011.572310.

PMID:
21504337
17.

Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products.

Jones A, Clary MJ, McDermott E, Coscia LA, Constantinescu S, Moritz MJ, Armenti VT.

Prog Transplant. 2013 Jun;23(2):153-7. doi: 10.7182/pit2013636.

PMID:
23782663
18.

Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).

Jongen PJ, Hengstman G, Hupperts R, Schrijver H, Gilhuis J, Vliegen JH, Hoogervorst E, van Huizen M, van Munster E, Samijn J, de Schryver E, Siepman T, Tonk M, Zandbergen E, ten Holter J, van der Kruijk R, Borm G.

BMC Neurol. 2011 Mar 30;11:40. doi: 10.1186/1471-2377-11-40.

19.

Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study.

Ratanajamit C, Vinther Skriver M, Jepsen P, Chongsuvivatwong V, Olsen J, Sørensen HT.

Scand J Infect Dis. 2003;35(4):255-9.

PMID:
12839155
20.

[Motherhood and fatherhood after liver transplantation].

Raakow R, Rayes N, Büscher U, Neuhaus R, Neuhaus P.

Dtsch Med Wochenschr. 1999 Jun 11;124(23):715-20. German.

PMID:
10396305
Items per page

Supplemental Content

Support Center